David Adlington is ranked #608 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

David Adlington (J.P. Morgan) — Analyst Ratings, Accuracy & Track Record

Q: How accurate are David Adlington's stock ratings?

About 80% of David's ratings were profitable over a one-year hold, with an average return of +5.1% per rating, measured by 13Foresight from historical prices.

Analyst Tracker/David Adlington

JPM

David Adlington

J.P. Morgan

Wall Street Analyst

★★★★☆

#608

on 13Foresight · ranked by our own returns

80%

Success Rate

+5.1%

Average Return

4 of 5 calls profitable · -7.7% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compare To ⓘ

📈 Across the calls we could measure, roughly 80% of David Adlington's ratings turned a profit when each position was held for 1 year — averaging +5.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

42 Buy 15 Hold 25 Sell

David's Stock Coverage 27 ratings · 2026-06-19

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return
DE:FRE Fresenius SE & Co. KGaA	Jun 02, 2026	BUY	Strong Buy +30.0% avg upside 19 analysts	$56.60 42.93% Upside	·
GB:CTEC ConvaTec	May 22, 2026	BUY	Strong Buy +40.1% avg upside 14 analysts	$294.00 41.96% Upside	·
CH:SOON Sonova Holding AG	May 19, 2026	HOLD	Sell +13.2% avg upside 17 analysts	$189.00 2.12% Downside	·
DE:AFX Carl Zeiss Meditec	May 13, 2026	SELL	Hold +91.1% avg upside 13 analysts	$21.70 13.01% Downside	·
DE:SHL Siemens Healthineers AG	May 12, 2026	BUY	Strong Buy +51.4% avg upside 22 analysts	$55.80 63.07% Upside	·
NL:PHIA Koninklijke Philips N.V.	May 07, 2026	HOLD	Buy +31.8% avg upside 20 analysts	$22.60 3.74% Downside	·
DE:FME Fresenius Medical Care AG & Co. KGaA	May 04, 2026	SELL	Buy +26.9% avg upside 21 analysts	$37.40 8.07% Downside	·
FR:BIM bioMerieux	Apr 24, 2026	HOLD	Buy +54.1% avg upside 12 analysts	$71.60 3.76% Upside	·
DE:GXI Gerresheimer	Feb 11, 2026	BUY	Buy +142.5% avg upside 14 analysts	$46.00 79.62% Upside	·
WILLF Demant	Feb 04, 2026	BUY	Strong Buy +10.9% avg upside 19 analysts	$38.84 9.66% Upside	+1.8%
SE:EKTA.B Elekta AB	Dec 08, 2025	SELL	Strong Sell +23.5% avg upside 12 analysts	$52.00 7.05% Upside	·
CH:ALC Alcon	Aug 21, 2025	HOLD	Buy +34.9% avg upside 35 analysts	$61.44 16.17% Upside	·
CH:STMN Straumann Holding AG	Aug 14, 2025	HOLD	Buy +15.7% avg upside 13 analysts	$125.00 19.51% Upside	·
GB:SN Smith & Nephew	Aug 06, 2025	BUY	Strong Buy +1311.5% avg upside 15 analysts	$1438.00 27.75% Upside	·
GB:SPI Spire Healthcare	Aug 05, 2025	BUY	Strong Buy +35.6% avg upside 5 analysts	$303.00 40.28% Upside	·
SE:GETI.B Getinge	Jul 21, 2025	SELL	Hold +14.1% avg upside 7 analysts	$165.00 14.86% Downside	·
GB:0K9P GN Store Nord	May 02, 2025	HOLD	Hold +170.2% avg upside 13 analysts	$135.00 52.31% Upside	·
SONVY Sonova Holding AG	Dec 03, 2024	SELL	Strong Sell +484.9% avg upside 1 analyst	$282.66 484.93% Upside	+24.6%
IT:AMP Amplifon S.p.A.	Oct 07, 2024	HOLD	Hold +155.9% avg upside 12 analysts	$33.70 229.67% Upside	·
PHG Koninklijke Philips	Dec 20, 2023	SELL	Buy +31.6% avg upside 13 analysts	$20.78 22.41% Downside	-9.3%
AMBFF Ambu	Nov 09, 2023	SELL	Hold +12.8% avg upside 2 analysts	$7.30 25.85% Downside	·
CH:MOVE Medacta Group SA	Mar 30, 2023	HOLD	Buy +11.0% avg upside 4 analysts	$93.00 30.44% Downside	·
GB:0QBO Coloplast A/S	Jan 25, 2023	HOLD	Buy +87.4% avg upside 16 analysts	$800.00 114.27% Upside	·
FMS Fresenius Medical Care	Feb 04, 2021	HOLD	Buy +97.5% avg upside 13 analysts	$59.34 151.51% Upside	+4.8%
EKTAY Elekta AB	Aug 03, 2020	HOLD	Sell 2 analysts	—	·
FR:EL EssilorLuxottica SA	Oct 25, 2018	HOLD	Strong Buy +12.0% avg upside 17 analysts	$104.19 39.99% Downside	·
SNN Smith & Nephew Snats	Jan 25, 2018	BUY	Buy +11.8% avg upside 13 analysts	—	+3.8%

🔒 22 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

David Adlington — Frequently Asked Questions

How accurate are David Adlington's stock ratings?

Based on the calls 13Foresight could measure, about 80% of David's ratings were profitable over a one-year hold, with an average return of +5.1% per rating, or -7.7% versus the S&P 500. We score every analyst the same way, from historical prices.

How is David ranked on 13Foresight?

David Adlington is currently ranked #608 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does David cover?

David most recently has ratings on DE:FRE, GB:CTEC, CH:SOON, DE:AFX, DE:SHL, NL:PHIA, DE:FME, FR:BIM, DE:GXI, WILLF, SE:EKTA.B, CH:ALC and 15 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Rating Distribution

Welcome to 13Foresight!